FRANKFURT (Reuters) -Swiss drugmaker Roche on Thursday lifted its full-year profit guidance, as cost cuts helped to offset ...

NEW YORK (Reuters) -Annual premiums for U.S. families with employer-sponsored health insurance in 2025 rose 6% to nearly ...

A meeting will be held to elect new board members following a disagreement between the board and its majority shareholder.

Eli Lilly was looking for infrastructure and an uncomplicated permit process for its $6.5M pharmaceutical manufacturing ...

According to a filing with the Securities and Exchange Commission dated October 21, 2025, Generali Asset Management reduced ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is spearheading a Phase ...

FRANKFURT () -Swiss drugmaker Roche on Thursday lifted its full-year profit guidance, even after nine-month sales were ...

MariTide is now progressing into phase 3 trials, with a focus on its long-term safety and efficacy. Amgen expects to apply ...

Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company’s biggest challenge: how to better tap into America’s ...

While the threat of tariffs dies down for the pharma industry, President Donald Trump is reportedly weighing a new ...

The restaurant will be a sibling business of Aroma Experience, which opened in 2024 as part of the Carmel City Center ...